Effects of aspirin and enoxaparin in a rat model of liver fibrosis

doi:10.3748/wjg.v23.i35.6412

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9850)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

660

WORD

206

HTML

5859

Figures (1-2)

360

Tables (1-3)

249

Sum=7334

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

900

Download

1616

Sum=2516

Sep 21, 2017 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 21, 2017; 23(35): 6412-6419
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412

Open in New Tab Full Size Figure Download Figure

Figure 1 General observations of the rat model of liver fibrosis/cirrhosis. A: Healthy control group; B: TAA group; C: TAA + low-dose aspirin group; D: TAA + high-dose aspirin group; and E: TAA + enoxaparin group. TAA: Thioacetamide.

Open in New Tab Full Size Figure Download Figure

Figure 2 Liver histopathology of rat liver fibrosis/cirrhosis. A: Liver histopathology in the model group at wk 8; B: Liver histopathology in the healthy control group at wk 12; C: Liver histopathology in the TAA group at wk 12; D: Liver histopathology in the TAA + low-dose aspirin group at wk 12; E: Liver histopathology in the TAA + high-dose aspirin group at wk 12; and F: Liver histopathology in the TAA + enoxaparin group at wk 12. Left: HE × 100; Right: Masson × 100. TAA: Thioacetamide.

Citation: Li CJ, Yang ZH, Shi XL, Liu DL. Effects of aspirin and enoxaparin in a rat model of liver fibrosis. World J Gastroenterol 2017; 23(35): 6412-6419
URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6412.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6412